Some providers discontinue the pyridoxine additive once the patient has been stable on the maintenance dose for several months without GI issues
Novo Nordisks USD 11 billion purchase of Catalent facilities in 2024 signals vertical integration aimed at securing pen-fill output
GLP-1 stimulates insulin secretion and inhibits glucagon secretion, thereby lowering blood sugar levels
Some people may notice positive changes in their appetite, such as reduced cravings or feeling more satisfied between meals, within a few weeks, but the most significant results are likely to happen when you reach the maintenance dose from around week 13 of treatment
Side Effects and Safety Profile Due to their related active ingredients and mechanisms of action, Semaglutide and Liraglutide share similar side effects
However, persistent or severe nausea might affect a persons eating habit or medication adherence, indirectly affecting blood sugar control